What's less understood is why drug companies spend millions for research on off-label uses for their services and products - uses that have been never satisfied with the FDA once the drug was submitted for approval. Off-label use allows drug businesses to obtain 'through the rear door' what they could never, and I am talking about never, break free with by going straight to the FDA for approval for a new use of a product - what's known today as an off-label use. You would hope that scientists would not corrupt the testing of a new, or off-label, utilization of a drug to deal with children by covering up their consulting fees from Big Pharma. But that is what happened. Harvard Medicine Re-search Fraud and Cover-up: How Off-Label Profiteering Works Medicine business money corrupts and impacts research. That's certain. What's less comprehended is why drug companies spend billions for research o-n off-label uses for their products - when the drug was submitted for approval uses which were never cleared using the FDA. Off-label use allows drug businesses to obtain 'through the back door' what they may never, and I mean never, get-away with by going right to the FDA for approval for a new use of a product - what's known today being an off-label use. You would hope that researchers wouldn't corrupt the commercial experimentation of-a new, or off-label, use of a drug to deal with children by covering up their consulting charges from Big Pharma. If you are concerned by reading, you will maybe want to compare about Zofran Lawsuit Update: Physicians Continue To Prescribe Drug “Off-Label”. But that is what happened. More important than what happened is why it happened and at the base of this can be a terrible mistake the U.S. has manufactured in allowing the exploitation of off-label use. To study additional information, please have a gander at: http://markets.buffalonews.com/buffnews/news/read/31112234/zofran_lawsuit_update. The devil is in the facts, therefore here is the story since it has unfolded. If you are interested in jewelry, you will maybe need to read about http://www.aztv.com/story/30632097/zofran-lawsuit-update-physicians-continue-to-prescribe-drug-off-label. Leading Harvard instructors studying off-label uses, the gold-mine of the drug industry, have broken National Institute of Health reporting requirements when over $10,000 is received from a subject organization, based on the New York Times, 'Researchers Neglect to Reveal Drug Pay' June 8, 2008. http://www.nytimes.com/2008/06/08/us/08conflict.html?em&ex=1213070400&en=9971013dfd33290a&ei=508720say20are%20sorry&st=cse is not enough. In the event people claim to dig up more about Zofran Lawsuit Update: Physicians Continue To Prescribe Drug “Off-Label”, we know about many on-line databases people should pursue. If Harvard does not fire them, it'll be complicit in the cover-up. Throw them off campus. Ring the bell loud and clear that regardless of how renown or outstanding, if you do not play by the principles, you can not play at all. And THEY should be forever banned by the NIH from receiving grants. Don't throw out the baby with the bath water. Once correct consequence is supported, give these experts a chance to shine their tarnished reputations. Permit them to conduct research under the guidance of a responsible administrator who knows that 'veritas,' means truth, accuracy, integrity, and uprightness and that it's more than only a slogan. Forward. Richard Alexander http://www.alexanderinjury.com.